Top compounds associated with response to MYBL2


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:MK-2206 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.15 7e-05
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.15 8e-05
mRNA 17-AAG GDSC1000 pan-cancer AAC -0.13 9e-05
mRNA Nutlin-3a (-) GDSC1000 pan-cancer AAC -0.14 0.0001
mRNA ciclopirox CTRPv2 pan-cancer AAC 0.13 0.0001
mRNA AZD7762 CTRPv2 pan-cancer AAC 0.13 0.0001
mRNA selumetinib:JQ-1 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 0.0001
mRNA TG-100-115 CTRPv2 pan-cancer AAC 0.15 0.0001
mRNA Crizotinib gCSI pan-cancer AAC -0.21 0.0002
mRNA KU-60019 CTRPv2 pan-cancer AAC 0.14 0.0002
Download CSV